Out-licensing: Research Tools & Cardiovascular/Cerebrovascular Disorders/Aneurysm

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..1 of 1 - per page
Order by

Modified versions of these tetracyclines were developed for applications directed toward the specific inhibition of calpains More

Displaying 1..1 of 1 - per page
Order by

Industry sector: Research tools del
Therapeutic target: Cardiovascular del; Cerebrovascular disorders del; Aneurysm del

Industry sector: Antibodies; Antigens; Biomarkers; Cell lines; Mouse models; Reagents; Vectors
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.